Detalhe da pesquisa
1.
Development and Characterization of MDR1 (Mdr1a/b) CRISPR/Cas9 Knockout Rat Model.
Drug Metab Dispos
; 47(2): 71-79, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30478157
2.
Characterization of in vitro Mrp2 transporter model based on intestinal organoids.
Regul Toxicol Pharmacol
; 108: 104449, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31449916
3.
Sorafenib reduces the production of epoxyeicosatrienoic acids and leads to cardiac injury by inhibiting CYP2J in rats.
Biochem Pharmacol
; 223: 116169, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548244
4.
Non-alcoholic fatty liver disease changes the expression and activity of hepatic drug-metabolizing enzymes and transporters in rats.
Toxicol Lett
; 396: 36-47, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38663832
5.
Construction and characterization of a humanized SLCO1B1 rat model with its application in evaluating the uptake of different statins.
Acta Pharm Sin B
; 14(4): 1592-1604, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572097
6.
A novel biosensor based on intestinal 3D organoids for detecting the function of BCRP.
Drug Deliv
; 24(1): 1453-1459, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28949254